Welcome to the
Besserer Lab (Project Team)
at Inserm Unit 1086 – Anticipe
Theranostic Innovations in Locally Aggressive Cancers
Welcome to the
at Inserm Unit 1086 – Anticipe
Pauline presented her poster “Fibroblast Activation Protein (FAP) as a Target for Radioligand Therapy in Glioblastoma” at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging held... Continue reading→
We received funding from the UCLA School of Medicine and the Jonsson Comprehensive Cancer Center for Tackling Glioblastoma Using Radioligand Therapy: The UCLA Neurotheranostics Program. The Neurotheranostics program that will bring... Continue reading→
Pétigny C, Dumont AA, Giguère H, Collette A, Holleran BJ, Iftinca M, Altier C, Besserer-Offroy É, Auger-Messier M, Leduc R. Monitoring TRPC7 Conformational Changes by BRET Following GPCR Activation. Int... Continue reading→